XAR

XAR is in a Stage 4 decline with a primary support failure indicating sellers remain in control. Price trades below declining 9/20/50/200 EMAs and rallies consistently fail, reinforcing a bearish medium-term bias. Short-term momentum is down with no clear exhaustion despite extreme oversold readings, favoring immediate downside participation. The long-term uptrend remains intact but is secondary to the prevailing downtrend.

• ↑Price gained 5.42% last week, reflecting sustained buy momentum.
• ↑Heightened geopolitical tensions expected to drive US defense budgets.
• ↓Insider selling in Rocket Lab (RKLB) raises volatility concerns.